NCT05911074View on ClinicalTrials.gov

COVID-19 Antigen Rapid Test Evaluation in Low-Prevalence Setting

CompletedOBSERVATIONAL
Enrollment

7,274

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Corona Virus Infection
Interventions
DIAGNOSTIC_TEST

The Abbott Panbio™ COVID-19 Ag Rapid Test

This is the intervention or medical device(s) intended to be used with a study participant according to the study protocol.

Trial Locations (1)

267

Botswana Harvard AIDS Institute Partnership, Gaborone

All Listed Sponsors
collaborator

Botswana Harvard AIDS Institute Partnership

OTHER

lead

Foundation for Innovative New Diagnostics, Switzerland

OTHER